ArticleMolecules (Basel, Switzerland)2017

Development of 2-Methoxyhuprine as Novel Lead for Alzheimer's Disease Therapy.

Eva Mezeiova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.